Response to inhaled ceftazidime in patients with non ‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa

ConclusionThe results suggest that inhaled ceftazidime in NCFB unrelated to PA is a plausible alternative to the standard therapies used in clinical practice.

Source: The Clinical Respiratory Journal - August 29, 2022 Category: Respiratory Medicine Authors: Vanessa Riveiro, Ana Casal, Jos é M. Álvarez‐Dobaño, Tamara Lourido, Pedro Suárez‐Artime, Carlota Rodríguez‐García, Lucía Ferreiro, María E. Toubes, Luis Valdés Tags: BRIEF REPORT Source Type: research